DrugDashboards

Cyanocobalamin

Cyanocobalamin · CYANOCOBALAMIN 1000 ug/mL · Injection, Solution · Intramuscular; Subcutaneous · Fresenius Kabi USA, LLC

NDC 63323-0044-01 · 25 VIAL, MULTI-DOSE in 1 TRAY / 1 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. The price is down 15% over the past year, to $1.49 per mL. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$1.49per MLinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicare Part B pays (ASP+6%)$0.6830per billing unit (1000 MCG)HCPCS J3420 · Jul 1, 2026
  • Federal contracts pay (FSS)$76.38per package of 25X1MLFresenius Kabi, LLC · May 15, 2025

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$5.00$10.00Nov 2013Sep 2026$1.49
154 price points · per MLSource: CMS NADAC

Estimated fill cost

WAC per package, as filed
$85.00
Reported to Texas DSHS · 2026 annual filing · Fresenius Kabi USA

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1000 MCG
$0.683
HCPCS J3420 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$346,286
50,664 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

10Low risk

Some pressure is visible, but not much — here’s everything the score found to count.

  • sterile injectable+10

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for cyanocobalamin (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA080557
TE code
AP
Approval date
Jan 1, 1982
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class II · TerminatedSep 27, 2012
    Fresenius Kabi USA, LLCLack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

Manufacturers of Cyanocobalamin (Injection, Solution)

LabelerStrengthFirst seenLast seen
American Regent, Inc.CYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 3, 2026
BluePoint LaboratoriesCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.CYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 3, 2026
Vitruvias TherapeuticsCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.CYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
AuroMedics Pharma LLCCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
NorthStar RxLLCCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
Somerset Therapeutics, LLCCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Aug 31, 2026
HF Acquisition Co LLC, DBA HealthFirstCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Aug 31, 2026
Zydus Lifesciences LimitedCYANOCOBALAMIN 1000 ug/mLJul 15, 2026Aug 31, 2026
Zydus Pharmaceuticals USA Inc.CYANOCOBALAMIN 1000 ug/mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Cyanocobalamin — NDC 63323-0044-01," retrieved September 3, 2026, https://drugdashboards.com/drug/63323004401.

Free to cite with attribution — see how the data is put together.